KV Securities Plaintiffs Fight Denial Of Bid To Amend
The plaintiffs in a securities lawsuit accusing KV Pharmaceutical Co. of making misstatements and omissions amid widespread drug recalls have appealed a judge's decision not to allow them to file an...To view the full article, register now.
Already a subscriber? Click here to view full article